Poor interrater reliability of hidradenitis suppurativa phenotypes - 16/08/18
Doi : 10.1016/j.jaad.2018.02.048
Kelsey R. van Straalen, MD a, Tim Verhagen a, Barbara Horváth, MD, PhD b, Christine Ardon, MD a, Allard R.J.V. Vossen, MD a, Rieke Driessen, MD, PhD c, Jurr Boer, MD, PhD d, Angelique L.V. Rondags, MD b, Errol P. Prens, MD, PhD a, Hessel H. van der Zee, MD, PhD a, ⁎ 
a Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands
b Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands
c Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
d Department of Dermatology, Deventer Hospital, Deventer, The Netherlands
∗Correspondence to: Hessel H. van der Zee, MD, PhD, Erasmus MC, Department of Dermatology, Room Gk-320, Po Box 2040, 3000CA, Rotterdam, The Netherlands.Erasmus MCDepartment of DermatologyRoom Gk-320, Po Box 2040, 3000CARotterdamThe Netherlands
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 3
P. 577-578 - septembre 2018 Retour au numéro
Article précédent
- Medicare Part D payments for brand and generic drugs prescribed by dermatologists
- Helen B. Powell, Adewole S. Adamson
- Dermatologists are the primary treating physicians of skin cancer in the United States Medicare population
- David M. Wang, Frederick C. Morgan, Robert J. Besaw, Chrysalyne D. Schmults
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?